Clinical trials
Active, not recruiting Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Bristol-Myers Squibb | 2 |
| Immunic AG | 2 |
| Novartis Pharmaceuticals | 2 |
| Terry L. Wahls | 2 |
| Amgen | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Antalya Training and Research Hospital | 1 |
| Biogen | 1 |
| Dent Neuroscience Research Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 29 |
| Multiple Sclerosis | 13 |
| Multiple Sclerosis, Chronic Progressive | 5 |
| Disease Progression | 1 |
| Fatigue | 1 |
| Hypoxia | 1 |
| Inflammation | 1 |
| Macular Edema | 1 |
| Malnutrition | 1 |
| Neoplasms | 1 |
Trials
Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.